BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29220674)

  • 1. ACTB Loss-of-Function Mutations Result in a Pleiotropic Developmental Disorder.
    Cuvertino S; Stuart HM; Chandler KE; Roberts NA; Armstrong R; Bernardini L; Bhaskar S; Callewaert B; Clayton-Smith J; Davalillo CH; Deshpande C; Devriendt K; Digilio MC; Dixit A; Edwards M; Friedman JM; Gonzalez-Meneses A; Joss S; Kerr B; Lampe AK; Langlois S; Lennon R; Loget P; Ma DYT; McGowan R; Des Medt M; O'Sullivan J; Odent S; Parker MJ; Pebrel-Richard C; Petit F; Stark Z; Stockler-Ipsiroglu S; Tinschert S; Vasudevan P; Villa O; White SM; Zahir FR; ; Woolf AS; Banka S
    Am J Hum Genet; 2017 Dec; 101(6):1021-1033. PubMed ID: 29220674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of a de novo ACTB mutation in a patient with atypical Baraitser-Winter syndrome.
    Johnston JJ; Wen KK; Keppler-Noreuil K; McKane M; Maiers JL; Greiner A; Sapp JC; ; Demali KA; Rubenstein PA; Biesecker LG
    Hum Mutat; 2013 Sep; 34(9):1242-9. PubMed ID: 23649928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frameshift mutation S368fs in the gene encoding cytoskeletal β-actin leads to ACTB-associated syndromic thrombocytopenia by impairing actin dynamics.
    Greve JN; Schwäbe FV; Pokrant T; Faix J; Di Donato N; Taft MH; Manstein DJ
    Eur J Cell Biol; 2022 Apr; 101(2):151216. PubMed ID: 35313204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prime-Editing of human ACTB in induced pluripotent stem cells to model human ACTB Loss-of-Function diseases and compensatory mechanisms.
    Binder S; Ramachandran H; Hildebrandt B; Dobner J; Rossi A
    Stem Cell Res; 2024 Mar; 75():103304. PubMed ID: 38217996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De Novo Missense Variants in WDR37 Cause a Severe Multisystemic Syndrome.
    Reis LM; Sorokina EA; Thompson S; Muheisen S; Velinov M; Zamora C; Aylsworth AS; Semina EV
    Am J Hum Genet; 2019 Aug; 105(2):425-433. PubMed ID: 31327510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical spectrum of individuals with de novo EBF3 variants or deletions.
    Nishi E; Uehara T; Yanagi K; Hasegawa Y; Ueda K; Kaname T; Yamamoto T; Kosaki K; Okamoto N
    Am J Med Genet A; 2021 Oct; 185(10):2913-2921. PubMed ID: 34050706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A likely pathogenic ACTG1 variant in a child showing partial phenotypic overlap with Baraitser-Winter syndrome.
    Graziani L; Cinnirella G; Ferradini V; Conte C; Bascio FL; Bengala M; Sangiuolo F; Novelli G
    Am J Med Genet A; 2023 Jun; 191(6):1565-1569. PubMed ID: 36810952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PUF60-related developmental disorder: A case series and phenotypic analysis of 10 additional patients with monoallelic PUF60 variants.
    Grimes H; Ansari M; Ashraf T; Cueto-González AM; Calder A; Day M; Fernandez Alvarez P; Foster A; Lahiri N; Repetto GM; Scurr I; Varghese V; Low KJ
    Am J Med Genet A; 2023 Oct; 191(10):2610-2622. PubMed ID: 37303278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A de novo ACTB gene pathogenic variant in identical twins with phenotypic variation for hydrops and jejunal atresia.
    Sibbin K; Yap P; Nyaga D; Heller R; Evans S; Strachan K; Alburaiky S; Nguyen HMA; Hermann-Le Denmat S; Ganley ARD; O'Sullivan JM; Bloomfield FH
    Am J Med Genet A; 2022 Apr; 188(4):1299-1306. PubMed ID: 34970864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a
    Nie K; Huang J; Liu L; Lv H; Chen D; Fan W
    Front Genet; 2022; 13():828120. PubMed ID: 35401677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De Novo
    Dawidziuk M; Kutkowska-Kazmierczak A; Bukowska-Olech E; Jurek M; Kalka E; Guilbride DL; Furmanek MI; Bekiesinska-Figatowska M; Bal J; Gawlinski P
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical delineation of SETBP1 haploinsufficiency disorder.
    Jansen NA; Braden RO; Srivastava S; Otness EF; Lesca G; Rossi M; Nizon M; Bernier RA; Quelin C; van Haeringen A; Kleefstra T; Wong MMK; Whalen S; Fisher SE; Morgan AT; van Bon BW
    Eur J Hum Genet; 2021 Aug; 29(8):1198-1205. PubMed ID: 33867525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COPB2 loss of function causes a coatopathy with osteoporosis and developmental delay.
    Marom R; Burrage LC; Venditti R; Clément A; Blanco-Sánchez B; Jain M; Scott DA; Rosenfeld JA; Sutton VR; Shinawi M; Mirzaa G; DeVile C; Roberts R; Calder AD; Allgrove J; Grafe I; Lanza DG; Li X; Joeng KS; Lee YC; Song IW; Sliepka JM; Batkovskyte D; Washington M; Dawson BC; Jin Z; Jiang MM; Chen S; Chen Y; Tran AA; Emrick LT; Murdock DR; Hanchard NA; Zapata GE; Mehta NR; Weis MA; Scott AA; Tremp BA; Phillips JB; Wegner J; Taylor-Miller T; Gibbs RA; Muzny DM; Jhangiani SN; Hicks J; Stottmann RW; Dickinson ME; Seavitt JR; Heaney JD; Eyre DR; ; Westerfield M; De Matteis MA; Lee B
    Am J Hum Genet; 2021 Sep; 108(9):1710-1724. PubMed ID: 34450031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further delineation of the clinical spectrum of White-Sutton syndrome: 12 new individuals and a review of the literature.
    Murch O; Jain V; Benneche A; Metcalfe K; Hobson E; Prescott K; Chandler K; Ghali N; Carmichael J; Foulds NC; Paulsen J; Smeland MF; Berland S; Fry AE
    Eur J Hum Genet; 2022 Jan; 30(1):95-100. PubMed ID: 34645992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling.
    Johnson BV; Kumar R; Oishi S; Alexander S; Kasherman M; Vega MS; Ivancevic A; Gardner A; Domingo D; Corbett M; Parnell E; Yoon S; Oh T; Lines M; Lefroy H; Kini U; Van Allen M; Grønborg S; Mercier S; Küry S; Bézieau S; Pasquier L; Raynaud M; Afenjar A; Billette de Villemeur T; Keren B; Désir J; Van Maldergem L; Marangoni M; Dikow N; Koolen DA; VanHasselt PM; Weiss M; Zwijnenburg P; Sa J; Reis CF; López-Otín C; Santiago-Fernández O; Fernández-Jaén A; Rauch A; Steindl K; Joset P; Goldstein A; Madan-Khetarpal S; Infante E; Zackai E; Mcdougall C; Narayanan V; Ramsey K; Mercimek-Andrews S; Pena L; Shashi V; ; Schoch K; Sullivan JA; Pinto E Vairo F; Pichurin PN; Ewing SA; Barnett SS; Klee EW; Perry MS; Koenig MK; Keegan CE; Schuette JL; Asher S; Perilla-Young Y; Smith LD; Rosenfeld JA; Bhoj E; Kaplan P; Li D; Oegema R; van Binsbergen E; van der Zwaag B; Smeland MF; Cutcutache I; Page M; Armstrong M; Lin AE; Steeves MA; Hollander ND; Hoffer MJV; Reijnders MRF; Demirdas S; Koboldt DC; Bartholomew D; Mosher TM; Hickey SE; Shieh C; Sanchez-Lara PA; Graham JM; Tezcan K; Schaefer GB; Danylchuk NR; Asamoah A; Jackson KE; Yachelevich N; Au M; Pérez-Jurado LA; Kleefstra T; Penzes P; Wood SA; Burne T; Pierson TM; Piper M; Gécz J; Jolly LA
    Biol Psychiatry; 2020 Jan; 87(2):100-112. PubMed ID: 31443933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HNRNPC haploinsufficiency affects alternative splicing of intellectual disability-associated genes and causes a neurodevelopmental disorder.
    Niggl E; Bouman A; Briere LC; Hoogenboezem RM; Wallaard I; Park J; Admard J; Wilke M; Harris-Mostert EDRO; Elgersma M; Bain J; Balasubramanian M; Banka S; Benke PJ; Bertrand M; Blesson AE; Clayton-Smith J; Ellingford JM; Gillentine MA; Goodloe DH; Haack TB; Jain M; Krantz I; Luu SM; McPheron M; Muss CL; Raible SE; Robin NH; Spiller M; Starling S; Sweetser DA; Thiffault I; Vetrini F; Witt D; Woods E; Zhou D; ; ; Elgersma Y; van Esbroeck ACM
    Am J Hum Genet; 2023 Aug; 110(8):1414-1435. PubMed ID: 37541189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up and novel variant in Suleiman-El-Hattab syndrome: Expanding the genotypic and clinical spectrum of a rare neurodevelopmental disorder.
    Sezer A; Kayhan G; Percin FE
    Eur J Med Genet; 2023 Sep; 66(9):104809. PubMed ID: 37474017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of exons 2 and 3 from Actb and cell immortalization lead to widespread, β-actin independent alterations in gene expression associated with cell cycle control.
    Sundby LJ; Southern WM; Sun J; Patrinostro X; Zhang W; Yong J; Ervasti JM
    Eur J Cell Biol; 2024 Feb; 103(2):151397. PubMed ID: 38387258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A homozygous nonsense mutation in DCBLD2 is a candidate cause of developmental delay, dysmorphic features and restrictive cardiomyopathy.
    Alhamoudi KM; Barhoumi T; Al-Eidi H; Asiri A; Nashabat M; Alaamery M; Alharbi M; Alhaidan Y; Tabarki B; Umair M; Alfadhel M
    Sci Rep; 2021 Jun; 11(1):12861. PubMed ID: 34145321
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.